Skip to content

Clinical Study on Qingfei Yihuo Capsule in Treating Asthma

Clinical Study on Qingfei Yihuo Capsule in Treating Asthma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOC-17013974
Enrollment
Unknown
Registered
2017-12-15
Start date
2017-12-13
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Qingfei Yihuo Capsule Group:Qingfei Yihuo Capsule
Placebo:Placebo

Sponsors

LongHua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of bronchial asthma, mild to moderate bronchial asthma (fever) acute exacerbation asthma patients; (2) meet the TCM syndrome (heat asthma) diagnostic criteria; (3) aged 18 to 75 years old, and can accept the treatment of observation and examination.

Exclusion criteria

Exclusion criteria: (1) patients with non-asthmatic and asthmatic patients in stable phase; (2) severe asthma and deadly asthma; (3) Patients younger than 18 years of age or older than 75 years: Pregnant or lactating women; (4) confirmed by the check tuberculosis, fungi, cancer and other factors caused by chronic wheeze; (5) with heart, liver and kidney disease and severe functional disorder patients; (6) Chronic pulmonary heart disease (decompensated cardiac function); (7) does not meet the inclusion criteria, mental or cognitive disorders, poor scientific compliance.

Design outcomes

Secondary

MeasureTime frame
Urine routine;Electrocardiogram;

Countries

China

Contacts

Public ContactHong Fang

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

1062718021@qq.com+86 13501886023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026